News

 (LOS ANGELES) –   In a significant leap forward for healthcare equity and accessibility, researchers at the University of Victoria and the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary system that combines remote health monitoring and drug delivery using 3D-printed hollow microneedles. This innovative approach, detailed in a recent study published in Advanced Healthcare Materials, promises to transform healthcare delivery, particularly for those in underserved or remote regions.

Read more ...

(LOS ANGELES) - Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have unveiled a pioneering study shedding light on the intricate mechanisms underlying Alzheimer's disease (AD). The study, titled "Effects of amyloid-β-mimicking peptide hydrogel matrix on neuronal progenitor cell phenotype," represents a significant leap forward in understanding the interplay between amyloid-like structures and neuronal cells.

Read more ...

Maximizes Production and Performance of Wearable Sound Amplifiers

(LOS ANGELES) – Scientists at the Terasaki Institute for Biomedical Innovation (TIBI) have employed artificial intelligence techniques to improve the design and production of nanofibers used in wearable nanofiber acoustic energy harvesters (NAEH). These acoustic devices capture sound energy from the environment and convert it into electrical energy, which can then be applied in useful devices, such as hearing aids.

Read more ...

The Terasaki Institute hosted its annual Open House 2024 which brought together the community of Woodland Hills, California, for an exploration of cutting-edge bioengineering research done in-house. Held over four hours, this event was a testament to the institute’s commitment to bridging the gap between research and translation, as well as science and the public.

Read more ...

(LOS ANGELES) – An extensive analytical study conducted at the Terasaki Institute for Biomedical Innovation (TIBI) has revealed an association between favorable survival outcomes for melanoma patients and the presence of higher populations of tissue-resident memory T cells (T_RM). Data obtained from this study could be used not only for a T_RM-based machine learning model with predictive powers for melanoma prognosis but could also elucidate the role T_RM cells can play in the tumor immune microenvironment. This could guide the development of more effective and personalized anti-tumor immunotherapeutic treatment regimens for cancer patients.

Read more ...

World leaders in academia and industry share their latest advances in bioengineering, discuss current trends in innovation, and network with their peers

(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) hosted their second annual Terasaki Innovation Summit on March 27-29, 2024, at the UCLA Meyer & Renee Luskin Center in Los Angeles. This year’s program focused on future directions in human and planetary health, as well as the latest trends in biomedical innovation and translation.

Read more ...